Common use of Licensavtalsenlig rätt Clause in Contracts

Licensavtalsenlig rätt. OP Företagsbanken Abp har rätt att använda indexet Solactive Europe & US Top Pharmaceuticals 2020 AR 5% Index i samband med emissionen av det här obligationslånet. OP Företagsbanken Abp är skyldig att införliva följande text i de här Lånespecifika villkoren: Solactive Europe & US Top Pharmaceuticals 2020 AR 5% Index The issue of the Securities is not sponsored, endorsed, sold, or promoted by any index to which the return on the Securities is linked (an Index, including any successor index) or any index sponsor of an Index to which the return on the Securities is linked (an Index Sponsor) and no Index Sponsor makes any representation whatsoever, whether express or implied, either as to the results to be obtained from the use of an Index and/or the levels at which an Index stands at any particular time on any particular date or otherwise. No Index or Index Sponsor shall be liable (whether in negligence or otherwise) to any person for any error in an Index and an Index Sponsor is under no obligation to advise any person of any error therein. No Index Sponsor is making any representation whatsoever, whether express or implied, as to the advisability of purchasing or assuming any risk in connection with the Securities. Neither the Issuer nor the Guarantor shall have any liability for any act or failure to act by an Index Sponsor in connection with the calculation, adjustment or maintenance of an Index. Except as disclosed prior to the Issue Date, neither the Issuer, the Guarantor nor their affiliates has any affiliation with or control over an Index or Index Sponsor or any control over the computation, composition or dissemination of an Index. Although the Calculation Agent will obtain information concerning an Index from publicly available sources it believes reliable, it will not independently verify this information. Accordingly, no representation, warranty or undertaking (express or implied) is made and no responsibility is accepted by the Issuer, the Guarantor, their affiliates or the Calculation Agent as to the accuracy, completeness and timeliness of information concerning an Index.

Appears in 1 contract

Samples: www.op.fi

Licensavtalsenlig rätt. OP Företagsbanken Abp har på basis av ett licensavtal rätt att använda an- vända indexet Solactive Europe & US Top Pharmaceuticals 2020 AR 5% Index MARKIT CDX North America High Yield S32 5y i samband med emissionen av det här obligationslånet. Enligt licens- avtalet är OP Företagsbanken Abp är skyldig att införliva följande text i de här Lånespecifika villkoren: Solactive Europe & US Top Pharmaceuticals 2020 AR 5% “The MARKIT CDX North America High Yield S32 5y (the “In- dex”) referenced herein is the property of Markit North America (“Index The issue of the Securities Sponsor”) and has been licensed for use in connection with “OP Kreditkorg Amerika 24/2019”. OP Corporate Bank plc acknowledges and agrees that “OP Kreditkorg Amerika 24/2019” is not sponsored, endorsed, sold, endorsed or promoted by any index to which the return on the Securities is linked (an Index, including any successor index) or any index sponsor of an Index to which the return on the Securities is linked (an Index Sponsor) and no Index . The In- dex Sponsor makes any no representation whatsoever, whether express or implied, and hereby expressly disclaims all warranties (including, without limitation, those of merchantability or fitness for a particular purpose or use), with respect to the Index or any data included therein or relating thereto, and in particular disclaims any warranty either as to the quality, accuracy and/or completeness of the Index or any data included therein, the results to be obtained from the use of an the Index and/or the levels composition of the Index at which any particular time on any particular date or otherwise and/or the creditworthiness of any entity, or the likelihood of the occurrence of a credit event or similar event (however defined) with respect to an obligation, in the Index stands at any particular time on any particular date or otherwise. No Index or The Index Sponsor shall not be liable (whether in negligence or otherwise) to the parties or any other person for any error in an Index the Index, and an Index the In- dex Sponsor is under no obligation to advise the parties or any person per- son of any error therein. No The Index Sponsor is making any makes no representation whatsoever, whether express or implied, as to the advisability of entering into, purchasing or assuming selling “OP Kreditkorg Amerika 24/2019”, the ability of the In- dex to track relevant markets’ performances, or otherwise relating to the Index or any risk transaction or product with respect thereto, or of as- suming any risks in connection with therewith. The Index Sponsor has no obligation to take the Securitiesneeds of any party into consideration in de- termining, composing or calculating the Index. Neither the Issuer No party entering into, purchasing or selling “OP Kreditkorg Amerika 24/2019, nor the Guarantor Index Sponsor, shall have any liability to any party for any act or failure to act by an the Index Sponsor in connection with the calculationdetermi- nation, adjustment adjustment, calculation or maintenance of an Index. Except as disclosed prior to the Issue Date, neither the Issuer, the Guarantor nor their affiliates has any affiliation with or control over an Index or Index Sponsor or any control over the computation, composition or dissemination of an Index. Although the Calculation Agent will obtain information concerning an Index from publicly available sources it believes reliable, it will not independently verify this information. Accordingly, no representation, warranty or undertaking (express or implied) is made and no responsibility is accepted by the Issuer, the Guarantor, their affiliates or the Calculation Agent as to the accuracy, completeness and timeliness of information concerning an Index.

Appears in 1 contract

Samples: www.op.fi

Licensavtalsenlig rätt. OP Företagsbanken Abp har på basis av ett licensavtal rätt att använda an- vända indexet Solactive Markit iTraxx Europe & US Top Pharmaceuticals 2020 AR 5% Index Crossover S33 i samband med emissionen av det här obligationslånet. Enligt licensavtalet är OP Företagsbanken Abp är skyldig att införliva följande text texter i de här Lånespecifika villkoren: Solactive “The Markit iTraxx Europe & US Top Pharmaceuticals 2020 AR 5% Crossover S33 (the “Index”) referenced herein is the property of Markit Indices GmbH (“Index The issue of the Securities Sponsor”) and has been licensed for use in connection with “OP Företagsränta Europa I/2020”. OP Corporate Bank plc acknowledges and agrees that “OP Företagsränta Europa I/2020” is not sponsored, endorsed, sold, endorsed or promoted by any index to which the return on the Securities is linked (an Index, including any successor index) or any index sponsor of an Index to which the return on the Securities is linked (an Index Sponsor) and no . The Index Sponsor makes any representation no repre- sentation whatsoever, whether express or implied, and hereby ex- pressly disclaims all warranties (including, without limitation, those of merchantability or fitness for a particular purpose or use), with re- spect to the Index or any data included therein or relating thereto, and in particular disclaims any warranty either as to the quality, ac- curacy and/or completeness of the Index or any data included therein, the results to be obtained from the use of an the Index and/or the levels at which an composition of the Index stands at any particular time on any particular date or otherwise and/or the creditworthiness of any entity, or the likelihood of the occurrence of a credit event or similar event (how- ever defined) with respect to an obligation, in the Index at any par- ticular time on any particular date or otherwise. No Index or The Index Sponsor shall not be liable (whether in negligence or otherwise) to the parties or any other person for any error in an Index the Index, and an the Index Sponsor is under no obligation to advise the parties or any person of any error er- ror therein. No The Index Sponsor is making any makes no representation whatsoever, whether express or implied, as to the advisability of entering into, purchasing or assuming selling “OP Företagsränta Europa I/2020”, the ability of the Index to track relevant markets’ performances, or otherwise relating to the Index or any risk transaction or product with respect thereto, or of as- suming any risks in connection with therewith. The Index Sponsor has no obligation to take the Securitiesneeds of any party into consideration in de- termining, composing or calculating the Index. Neither the Issuer No party entering into, purchasing or selling “OP Företagsränta Europa I/2020”, nor the Guarantor Index Sponsor, shall have any liability to any party for any act or failure to act by an the Index Sponsor in connection with the calculationdetermi- nation, adjustment adjustment, calculation or maintenance of an the Index.” “The Markit CDX North American High Yield S33 (the “Index”) referenced herein is the property of Markit North America, Inc. (“In- dex Sponsor”) and has been licensed for use in connection with “OP Företagsränta Europa I/2020”. Except as disclosed prior OP Corporate Bank plc acknowl- edges and agrees that “OP Företagsränta Europa I/2020” is not spon- sored, endorsed or promoted by the Index Sponsor. The Index Spon- sor makes no representation whatsoever, whether express or im- plied, and hereby expressly disclaims all warranties (including, without limitation, those of merchantability or fitness for a particular purpose or use), with respect to the Issue DateIndex or any data included therein or relating thereto, neither and in particular disclaims any warranty either as to the Issuerquality, accuracy and/or completeness of the Index or any data included therein, the Guarantor nor their affiliates has results obtained from the use of the Index and/or the composition of the Index at any affiliation particular time on any particular date or otherwise and/or the creditworthiness of any entity, or the likelihood of the occurrence of a credit event or similar event (however defined) with respect to an obligation, in the Index at any particular time on any particular date or control over an Index or otherwise. The Index Sponsor shall not be liable (whether in negligence or otherwise) to the parties or any control over other person for any error in the computationIndex, composition and the In- dex Sponsor is under no obligation to advise the parties or dissemination any per- son of an Indexany error therein. Although the Calculation Agent will obtain information concerning an The Index from publicly available sources it believes reliableSponsor makes no representation whatsoever, it will not independently verify this information. Accordingly, no representation, warranty or undertaking (whether express or implied) is made and no responsibility is accepted by the Issuer, the Guarantor, their affiliates or the Calculation Agent as to the accuracyadvisability of entering into, completeness and timeliness purchasing or selling “OP Företagsränta Europa I/2020”, the ability of information concerning an the Index to track relevant markets’ performances, or otherwise relating to the Index or any transaction or product with respect thereto, or of as- suming any risks in connection therewith. The Index Sponsor has no obligation to take the needs of any party into consideration in de- termining, composing or calculating the Index. No party entering into, purchasing or selling“OP Företagsränta Europa I/2020”, nor the Index Sponsor, shall have any liability to any party for any act or failure to act by the Index Sponsor in connection with the determi- nation, adjustment, calculation or maintenance of the Index.

Appears in 1 contract

Samples: www.op.fi

Licensavtalsenlig rätt. OP Företagsbanken Abp har på basis av ett licensavtal rätt att använda an- vända indexet Solactive Markit iTraxx Europe & US Top Pharmaceuticals 2020 AR 5% Index Crossover S37 i samband med emissionen av det här obligationslånet. Enligt licensavtalet är OP Företagsbanken Abp är skyldig att införliva följande text texter i de här Lånespecifika villkoren: Solactive “The Markit iTraxx Europe & US Top Pharmaceuticals 2020 AR 5% Crossover S37 (the “Index”) referenced herein is the property of Markit Indices Limited (“Index The issue of the Securities Sponsor”) and has been licensed for use in connection with “OP Yrityskorko Eurooppa I/2022”. OP Corporate Bank plc acknowledges and agrees that “OP Yrityskorko Eurooppa I/2022” is not sponsored, endorsed, sold, endorsed or promoted by any index to which the return on the Securities is linked (an Index, including any successor index) or any index sponsor of an Index to which the return on the Securities is linked (an Index Sponsor) and no . The Index Sponsor makes any no representation whatsoever, whether express or implied, and hereby expressly disclaims all warranties (including, without limitation, those of merchantability or fitness for a particular purpose or use), with respect to the Index or any data included therein or relating thereto, and in particular disclaims any warranty either as to the quality, accuracy and/or completeness of the Index or any data in- cluded therein, the results to be obtained from the use of an the Index and/or the levels at which an composition of the Index stands at any particular time on any particular date or otherwise and/or the creditworthiness of any entity, or the likelihood of the occurrence of a credit event or similar event (how- ever defined) with respect to an obligation, in the Index at any par- ticular time on any particular date or otherwise. No Index or The Index Sponsor shall not be liable (whether in negligence or otherwise) to the parties or any other person for any error in an Index the Index, and an the Index Sponsor is under no obligation to advise the parties or any person of any error er- ror therein. No The Index Sponsor is making any makes no representation whatsoever, whether express or implied, as to the advisability of entering into, purchasing or assuming selling “OP Yrityskorko Eurooppa I/2022”, the ability of the In- dex to track relevant markets’ performances, or otherwise relating to the Index or any risk transaction or product with respect thereto, or of as- suming any risks in connection with therewith. The Index Sponsor has no obligation to take the Securitiesneeds of any party into consideration in de- termining, composing or calculating the Index. Neither the Issuer No party entering into, purchasing or selling “OP Yrityskorko Eurooppa I/2022”, nor the Guarantor Index Sponsor, shall have any liability to any party for any act or failure to act by an the Index Sponsor in connection with the calculationdetermi- nation, adjustment adjustment, calculation or maintenance of an Index. Except as disclosed prior to the Issue Date, neither the Issuer, the Guarantor nor their affiliates has any affiliation with or control over an Index or Index Sponsor or any control over the computation, composition or dissemination of an Index. Although the Calculation Agent will obtain information concerning an Index from publicly available sources it believes reliable, it will not independently verify this information. Accordingly, no representation, warranty or undertaking (express or implied) is made and no responsibility is accepted by the Issuer, the Guarantor, their affiliates or the Calculation Agent as to the accuracy, completeness and timeliness of information concerning an Index.” 7. Information om Administratör av in- dex/Referensränta: Den Underliggande tillgången tillhandahålls av en Administratör som ingår i ett sådant register som i enlighet med Referensvärdes- förordningen förs av ESMA. Administratör av Underliggande tillgången är Markit.

Appears in 1 contract

Samples: www.op.fi